25 October, 2023
Cumulus Neuroscience Presents Data at CTAD 2023 Annual Meeting
18 October, 2023
Cumulus Neuroscience to Present Data at CTAD 2023 Annual Meeting
10 October, 2023
Cumulus Neuroscience Presents Data at ECNP 2023 Annual Meeting
28 September, 2023
Cumulus Neuroscience to Present Data at ECNP 2023 Annual Meeting
17 July, 2023
Cumulus Neuroscience Presents Data at AAIC 2023 Annual Meeting and Technology and Dementia Preconference
13 July, 2023
Cumulus Neuroscience Announces Research Collaboration with the Universities of Bath and Bristol on Development of Breakthrough Test for Early Detection of Alzheimer's Dementia
12 July, 2023
Cumulus Neuroscience Presents Key Data at the 2023 ENCALS Annual Meeting on Patients with Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD)
11 July, 2023
Cumulus Neuroscience to Present Data at AAIC 2023 Annual Meeting and Technology and Dementia Preconference
6 July, 2023
Cumulus Neuroscience to Present Data at 2023 ENCALS Annual Meeting on Patients with Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD)
31 May, 2023
Cumulus Neuroscience Completes Patient Enrollment for Pivotal CNS-101 Early-stage Alzheimer’s Dementia Validation Trial
23 May, 2023
Cumulus Neuroscience to Present Data at 2023 ASCP Annual Meeting
4 May, 2023
Cumulus Neuroscience Receives FDA 510(k) Clearance for Award-Winning, First-In-Class Neurophysiology Platform for At-Home Use
2 May, 2023
Cumulus Neuroscience Appoints Tina Sampath as Chief Commercial Officer, Strengthening Leadership Team Amid Continued Company Growth
27 April, 2023
Cumulus Neuroscience Lands Coveted iF Design and Red Dot Awards for Innovative At-Home EEG Device
11 April, 2023
Cumulus Neuroscience Expands Development Support of Novel Precision CNS Therapeutics
1 February, 2023
Cumulus Neuroscience Expands Executive Team, Supporting Biopharma Business Growth